Who is sponsoring NCT03240913?

NCT03240913 is sponsored by University of Calgary.

What drugs are being tested in NCT03240913?

Interventions in NCT03240913: Baseline and Follow-up Surveys, Patient Reported Outcome Measure informed Decision Aid, Pamphlet.

What condition does NCT03240913 study?

NCT03240913 studies Knee Osteoarthritis, Total Knee Arthroplasty.

Is NCT03240913 still recruiting?

NCT03240913 is currently completed. Last updated 28 April 2020.

Last reviewed 2020-04-28 · How we verify

NCT03240913

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A PROMs Based Educational Tool (PROM-DA) for Patients Considering Total Knee Arthroplasty

Completed NA Last updated 28 April 2020

What this trial tests

NA trial testing Baseline and Follow-up Surveys in Knee Osteoarthritis in 163 participants. Completed in 3 March 2020.

Timeline

19 June 2017

Primary endpoint
18 October 2018

3 March 2020

Quick facts

Lead sponsor	University of Calgary
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	163
Start date	19 June 2017
Primary completion	18 October 2018
Estimated completion	3 March 2020
Sites	1 location across Canada

Drugs / interventions tested

Baseline and Follow-up Surveys
Patient Reported Outcome Measure informed Decision Aid
Pamphlet

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Total Knee Arthroplasty — all drugs for Total Knee Arthroplasty →

Sponsor

University of Calgary

Who can join

30 and older, any sex, with Knee Osteoarthritis or Total Knee Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objectives of this study are to: 1) develop an educational tool known as the Patient Reported Outcome Measure informed Decision Aid (PROM-DA) that will describe the options for patients considering total knee arthroplasty (TKA) surgery, and help them imagine what to expect if they choose either option; 2) assess the extent that the PROM-DA improves patients decision quality; 3) determine the feasibility of a larger trial to test the PROM-DA in multiple sites and more patients.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Decision aids for people facing health treatment or screening decisions.
Stacey D, Lewis KB, Smith M, Carley M, et al · · 2024 · cited 203× · PMID 38284415 · DOI 10.1002/14651858.cd001431.pub6
Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice.
Gibbons C, Porter I, Gonçalves-Bradley DC, Stoilov S, et al · · 2021 · cited 146× · PMID 34637526 · DOI 10.1002/14651858.cd011589.pub2
An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a pragmatic randomized controlled trial.
Bansback N, Trenaman L, MacDonald KV, Hawker G, et al · · 2019 · cited 35× · PMID 30797238 · DOI 10.1186/s12891-019-2434-2
An online individualised patient decision aid improves the quality of decisions in patients considering total knee arthroplasty in routine care: A randomized controlled trial.
Bansback N, Trenaman L, MacDonald KV, Durand D, et al · · 2022 · cited 29× · PMID 36474942 · DOI 10.1016/j.ocarto.2022.100286

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other University of Calgary trials

Trials by the same sponsor.

NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03240913 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Calgary
Last refreshed: 28 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03240913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing